In conclusion, our study did not demonstrate a significant association between P-gp expression and clinical outcomes, CTx response, and prognosis in osteosarcoma, suggesting that P-gp may not be a useful biomarker for CTx selection or prognosis prediction in osteosarcoma. Here, PGP is linked to osteosarcoma.